Analysis of colorectal cancer patients at Xijing Hospital since 2011
Colorectal Cancer Dataset in Xijing Hospital From 2011
This study looks at the different treatment methods and outcomes for colorectal cancer patients who had surgery at Xijing Hospital since 2011 to see how they compare.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Xijing Hospital Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Trial ID | NCT06308354 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze clinical pathological differences, treatment approaches, and prognosis among colorectal cancer patients who underwent surgery at Xijing Hospital. It includes patients diagnosed with various forms of colorectal adenocarcinoma, including hereditary syndromes. The study will utilize comprehensive medical records and pathological information to identify trends and outcomes in this patient population.
Who should consider this trial
Good fit: Ideal candidates include patients with pathologically confirmed colorectal adenocarcinoma diagnosed between 2013 and 2023.
Not a fit: Patients with other types of colorectal malignancies, benign lesions, or recurrent cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of colorectal cancer prognosis and treatment, potentially leading to improved patient outcomes.
How similar studies have performed: While similar observational studies have been conducted, this specific analysis of colorectal cancer patients at Xijing Hospital may provide novel insights into treatment and prognosis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome; * 2\. Visit our center with complete medical records and pathological information; * 3\. Colorectal cancer patients diagnosed between 2013 and 2023. Exclusion Criteria: * 1\. The patient has other colorectal malignancies other than adenocarcinoma; * 2\. Malignant tumors adjacent to organs invading the colon and rectum; * 3\. Malignant tumors from distant organs metastasize to the colon and rectum; * 4\. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.
Where this trial is running
Xi'an, Shaanxi
- Fourth Military Medical University — Xi'an, Shaanxi, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.